| Previous Close | 37.36 |
| Open | 37.25 |
| Bid | 34.00 x 100 |
| Ask | 39.00 x 100 |
| Day's Range | 36.98 - 37.46 |
| 52 Week Range | 35.15 - 46.80 |
| Volume | 3,127,078 |
| Avg. Volume | 3,097,507 |
| Market Cap | 10.41B |
| Beta | 0.63 |
| PE Ratio (TTM) | 13.83 |
| EPS (TTM) | 2.68 |
| Earnings Date | Oct 31, 2017 - Nov 6, 2017 |
| Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 47.43 |
- PR Newswire•6 days ago
New USPSTF Draft Cervical Cancer Screening Recommendations Are a Step Back for Women's Health, Would Put Lives at Risk
MARLBOROUGH, Mass. , Sept. 14, 2017 /PRNewswire/ --Â Hologic, Inc. (Nasdaq: HOLX) is deeply concerned that the United States Preventive Services Task Force (USPSTF) did not include a grade for co-testing ...
- Associated Press•7 days ago
Western Digital and Hologic skid; Centene, Nordstrom climb
Stocks that moved substantially or traded heavily on Wednesday: Centene Corp., up $7.28 to $98.16 The health insurer and Medicaid coverage provider will expand into New York by buying Fidelis Care for ...
- Zacks•9 days ago
Hologic (HOLX) Down 11.1% Since Earnings Report: Can It Rebound?
Hologic (HOLX) reported earnings more than a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
